Literature DB >> 1711142

Antigenic similarities in lipopolysaccharides of Haemophilus and Neisseria and expression of a digalactoside structure also present on human cells.

M Virji1, J N Weiser, A A Lindberg, E R Moxon.   

Abstract

Monoclonal antibodies raised against Haemophilus influenzae and Neisseria gonorrhoeae were used to investigate similarities or differences in the lipopolysaccharide antigens of pathogenic and commensal strains of several Gram-negative bacteria indigenous to mucosal surfaces of humans. In immunoblotting experiments, 20 of 36 monoclonal antibodies showed cross-reactions between species of Neisseria and Haemophilus. The common epitopes were present on N. gonorrhoeae, N. meningitidis, N. lactamica, H. influenzae including biogroup aegyptius, and occasionally H. parainfluenzae. No other commensal Neisseria or Gram-negative organisms tested reacted with the monoclonal antibodies with one exception; a single strain of pathogenic Escherichia coli was recognised by a N. gonorrhoeae-specific monoclonal antibody. One monoclonal antibody, raised against N. gonorrhoeae lipopolysaccharide, reacted with N. gonorrhoeae (32 of 59 strains), N. meningitidis (9 of 26 strains), H. influenzae (6 of 16 strains). An epitope expressed by H. influenzae and implicated in its virulence was also present on 14 of 59 strains of N. gonorrhoeae and was shown to comprise a digalactoside structure, alpha-galactosyl-1,4-beta-galactose (Gal alpha 1,4Gal beta), also found on human cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1711142     DOI: 10.1016/0882-4010(90)90062-u

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  21 in total

Review 1.  Challenge of investigating biologically relevant functions of virulence factors in bacterial pathogens.

Authors:  R Moxon; C Tang
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-05-29       Impact factor: 6.237

Review 2.  Functional genomics of pathogenic bacteria.

Authors:  E R Moxon; D W Hood; N J Saunders; E K H Schweda; J C Richards
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-01-29       Impact factor: 6.237

3.  Identification of a new locus involved in expression of Haemophilus influenzae type b lipooligosaccharide.

Authors:  G P Jarosik; E J Hansen
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

4.  DNA repeats identify novel virulence genes in Haemophilus influenzae.

Authors:  D W Hood; M E Deadman; M P Jennings; M Bisercic; R D Fleischmann; J C Venter; E R Moxon
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

Review 5.  Short-sequence DNA repeats in prokaryotic genomes.

Authors:  A van Belkum; S Scherer; L van Alphen; H Verbrugh
Journal:  Microbiol Mol Biol Rev       Date:  1998-06       Impact factor: 11.056

6.  Immunogenicity of outer membrane proteins in a lipopolysaccharide-deficient mutant of Neisseria meningitidis: influence of adjuvants on the immune response.

Authors:  L Steeghs; B Kuipers; H J Hamstra; G Kersten; L van Alphen; P van der Ley
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

7.  The tetrasaccharide L-alpha-D-heptose1-->2-L-alpha-D-heptose1--> 3-L-alpha-D-heptose1-->(3-deoxy-D-manno-octulosonic acid) and phosphate in lipid A define the conserved epitope in Haemophilus lipopolysaccharides recognized by a monoclonal antibody.

Authors:  S Borrelli; O Hegedus; D H Shaw; P E Jansson; A A Lindberg
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

Review 8.  Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.

Authors:  A F Verheul; H Snippe; J T Poolman
Journal:  Microbiol Rev       Date:  1993-03

9.  Generation of lipooligosaccharide mutants of Haemophilus influenzae type b.

Authors:  R McLaughlin; S M Spinola; M A Apicella
Journal:  J Bacteriol       Date:  1992-10       Impact factor: 3.490

10.  Lipooligosaccharides (LOS) of some Haemophilus species mimic human glycosphingolipids, and some LOS are sialylated.

Authors:  R E Mandrell; R McLaughlin; Y Aba Kwaik; A Lesse; R Yamasaki; B Gibson; S M Spinola; M A Apicella
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.